The Prognostic Assessment of CDC20 in Patients with Renal Clear Cell Carcinoma and Its Relationship with Body Immunity

Figure 1

The expression of CDC20 in KIRC tissues: (a) the expression of CDC20 in different tumor tissues through the TCGA database; (b) the relative expression of CDC20 molecules in KIRC tissues and normal tissues in TCGA dataset; (c) paired box plots corresponding to the differential expression of CDC20 between KIRC and normal tissues in TCGA dataset; (d) CDC20 expression in KIRC tissue and normal kidney tissue in GSE15641 dataset; (e–g) the OS, DSS, and PFI curves of KIRC patients with high and low expression of CDC20 in the TCGA database.

(a)

(b)

(c)

(d)

(e)

(f)

(g)